We are live on ! Find out more
CI

Capital International Portfolio holdings

AUM $2.7B
1-Year Est. Return 31.08%
This Fund
S&P 500
This Quarter Est. Return
+7.91%
1 Year Est. Return
+31.08%
3 Year Est. Return
+123.92%
5 Year Est. Return
+171.61%
10 Year Est. Return
+862.17%
AUM
$1.53B
AUM Growth
-$95.6M
Cap. Flow
-$222M
Cap. Flow %
-14.52%
Top 10 Hldgs %
31.26%
Holding
169
New
8
Increased
27
Reduced
80
Closed
11

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$45.1M
2
HAL icon
Halliburton
HAL
+$19.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$14.6M
4
KMI icon
Kinder Morgan
KMI
+$12.4M
5
TFC icon
Truist Financial
TFC
+$11M

Sector Composition

Rank Sector Weight
1 Healthcare 17.6%
2 Financials 12.98%
3 Energy 11.33%
4 Consumer Discretionary 10.47%
5 Technology 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$109M 7.12%
1,728,200
-753,800
-30% -$45.1M
BMY icon
2
Bristol-Myers Squibb
BMY
$124B
$56.1M 3.68%
1,211,600
-333,500
-22% -$14.6M
GS icon
3
Goldman Sachs
GS
$314B
$48.9M 3.21%
309,300
-23,000
-7% -$3.7M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.22T
$45.1M 2.96%
2,069,167
-109,609
-5% -$2.42M
CVX icon
5
Chevron
CVX
$373B
$41.5M 2.72%
341,329
-10,800
-3% -$1.33M
DHR icon
6
Danaher
DHR
$144B
$41.2M 2.7%
884,814
-69,035
-7% -$3.13M
AAPL icon
7
Apple
AAPL
$4.9T
$35.1M 2.3%
2,062,816
-144,200
-7% -$2.39M
ETN icon
8
Eaton
ETN
$155B
$33.9M 2.22%
492,200
-90,000
-15% -$6.04M
VRSN icon
9
VeriSign
VRSN
$25.3B
$33.8M 2.21%
664,000
+173,500
+35% +$8.38M
CME icon
10
CME Group
CME
$88.5B
$32.7M 2.14%
442,700
-73,327
-14% -$5.4M
HAL icon
11
Halliburton
HAL
$29.4B
$32.4M 2.12%
673,027
-422,273
-39% -$19.8M
ORCL icon
12
Oracle
ORCL
$364B
$29M 1.9%
873,400
-141,700
-14% -$4.6M
CVE icon
13
Cenovus Energy
CVE
$52.1B
$28.8M 1.89%
962,600
-144,600
-13% -$4.27M
SLB icon
14
SLB Ltd
SLB
$70.3B
$27.5M 1.8%
310,996
-54,700
-15% -$4.49M
AMT icon
15
American Tower
AMT
$79.2B
$25M 1.64%
337,300
-46,100
-12% -$3.33M
PG icon
16
Procter & Gamble
PG
$349B
$24.7M 1.62%
327,200
-12,200
-4% -$971K
V icon
17
Visa
V
$682B
$24.2M 1.59%
507,080
-91,200
-15% -$4.21M
CMCSA icon
18
Comcast
CMCSA
$85B
$24M 1.57%
1,062,600
-422,800
-28% -$9.21M
TFC icon
19
Truist Financial
TFC
$65.4B
$23.4M 1.53%
693,600
-314,000
-31% -$11M
BA icon
20
Boeing
BA
$169B
$22.9M 1.5%
194,800
-13,100
-6% -$1.41M
MRSH
21
Marsh
MRSH
$87.8B
$21.9M 1.44%
503,400
-82,500
-14% -$3.47M
RTX icon
22
RTX Corp
RTX
$261B
$21M 1.38%
309,378
-53,867
-15% -$3.52M
SGEN
23
DELISTED
Seagen Inc. Common Stock
SGEN
$20.9M 1.37%
477,400
-138,400
-22% -$5.76M
SBUX icon
24
Starbucks
SBUX
$120B
$20.6M 1.35%
535,298
-93,600
-15% -$3.36M
BLK icon
25
Blackrock
BLK
$166B
$19.6M 1.29%
72,600
-6,973
-9% -$1.89M

Similar funds

Capital International's Q3 2013 Portfolio in Review

As of Q3 2013, Capital International held 169 positions worth $1.53B, down 5.9% from $1.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Capital International withdrew a net $222M in Q3 2013, closing 11 positions and reducing 80 holdings. Its most notable exit was Kinder Morgan, an estimated $12.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Energy.

Against the trend, Capital International opened a new position in Enbridge worth $5.72M.

  • Capital International's largest Q3 2013 buy was Enbridge: 136,800 shares worth $5.72M.
  • Capital International added most to VeriSign in Q3 2013, an estimated $8.38M increase.
  • Capital International's biggest Q3 2013 reduction was Gilead Sciences, cutting an estimated $45.1M.
  • Capital International fully exited Kinder Morgan in Q3 2013, selling an estimated $12.4M.
  • Capital International's ten largest holdings make up 31% of its $1.53B portfolio in Q3 2013.
  • Capital International opened 8 new positions and closed 11 in Q3 2013.
  • Capital International's portfolio value fell 5.9% quarter-over-quarter to $1.53B.

Based on Capital International's 13F filing for Q3 2013, filed 14 Nov 2013.